Skip to content

Local Cellular INTeraction and ACTivation of Platelets in Abdominal Aortic Aneurysm

Local Cellular INTeraction and ACTivation of Platelets in Abdominal Aortic Aneurysm

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00041159
Enrollment
212
Registered
2026-07-28
Start date
2021-02-09
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I71.4

Interventions

Group 1: Investigation of the AAA-specific pathogenic relevance of platelet activation states, erythrocyte-associated effects, and their relationship to the size and/or progression of abdominal aortic

Sponsors

Universitätsklinikum Düsseldorf
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients presenting for blood donation at the blood bank who have provided informed consent for the use of their blood samples for experimental research purposes as part of the ATLaNtA study (2018-140_2KFogU: “Potential activation mechanisms and interactions of platelets in degenerative diseases of the liver, brain, and aorta – ATLaNtA study”). Patients with AAA/TAA fulfilling guideline-based indications for endovascular aneurysm repair (study cohort). Patients with AAA/TAA presenting for routine follow-up examinations at the vascular outpatient clinic. Patients with other atherosclerotic vascular diseases (excluding AAA/TAA), including peripheral arterial occlusive disease (PAOD) or carotid artery stenosis, presenting for routine follow-up examinations at the vascular outpatient clinic. Age =18 years. Technically feasible blood collection. Written informed consent.

Exclusion criteria

Exclusion criteria: • Lack of a declaration of consent • Psychiatric disorders and the resulting legal incapacity • Known blood clotting disorders • Known genetic platelet disorders

Design outcomes

Primary

MeasureTime frame
Assessment of the association and/or correlation between AAA/TAA size and/or disease progression and platelet activation status as well as erythrocyte-specific prothrombotic propensity. Study parameters will be reassessed every six months based on the collected analyses.

Secondary

MeasureTime frame
Identification of platelet- and/or erythrocyte-specific markers as potential biomarkers for abdominal and thoracic aortic aneurysm (AAA/TAA).

Countries

Germany

Contacts

Public ContactKim Krott

Universitätsklinikum Düsseldorf

kim-juergen.krott@med.uni-duesseldorf.de+49 0211 81 04149

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 10, 2026